Zydus completes phase III trials of Diabetes drug in India: Company

"The trial was a multi-centric, randomised, double blind study to evaluate the safety and efficacy of 2mg and 4mg of Saroglitazar compared to Pioglitazone 45mg in patients with type 2 Diabetes Mellitus.

from Moneycontrol Business News https://ift.tt/2Kxa80H